(MedPage Today) — CHICAGO — The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer decreased by 50% in patients who received immunotherapy in addition to adjuvant chemotherapy, a large randomized trial…
Source link : https://www.medpagetoday.com/meetingcoverage/asco/115839
Author :
Publish date : 2025-06-01 16:50:00
Copyright for syndicated content belongs to the linked Source.
